---
figid: PMC7690808__cancers-12-03099-g001
figlink: pmc/articles/PMC7690808/figure/cancers-12-03099-f001/
number: Figure 1
caption: Transforming growth factor-β (TGF-β) signalling pathways in tumorigenesis.
  The dual roles of TGF-β signalling pathways have been demonstrated in tumorigenesis.
  TGF-β is a tumour suppressor in TME development of early-stage cancer and a tumour
  promoter in malignancy processes of advanced-stage cancer. Schematic diagramme (above)
  showing TGF-β signalling and its role in cancer tumorigenesis and progression as
  well as tumour suppression. TGF-β binds to TGFBR2 which then complexes with TGFBR1
  to activate downstream signalling. TGF-β can activate both Smad-dependent canonical
  and Smad-independent non-canonical signalling cascades. The TGF-β activated TGFBR1
  phosphorylates the Smad2/3 complex which then associates Smad4, before translocating
  to the nucleus to regulate the transcription of different targeted genes involved
  in tumour suppression during tumorigenesis (e.g., p15INK4b and p21Cip1), as well
  as tumour progression (e.g., Snail and Vimentin). The Smad-dependent TGF-β canonical
  signalling pathway can also be antagonised by Smad7 through inhibiting the binding
  of the Smad2/3 complex with Smad4. In the Smad-independent non-canonical signalling
  cascades, the activated TGFBR1/2 receptors induce downstream signalling through
  the Ras/Raf/MAPKs (JNK/p38/ERK), PI3K/AKT, MAP3K7(TAK1)/NF-κB, and Rho family of
  small GTPase-dependent signalling pathways. The TGF-β activated JNK/p38/ERK-MAPKs
  also crosstalk with Smad2/3/4 to modulate downstream signalling to influence cancer
  development. The Rho family of small GTPase-dependent signalling pathways (e.g.,
  Rho/ROCK) are involved in epithelial–mesenchymal transition (EMT). The activated
  PI3K/AKT pathway induces mTOR to promote cell proliferation and EMT. The TGF-β signals
  also activate NF-κB signalling to modulate inflammatory response.
pmcid: PMC7690808
papertitle: 'Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity.'
reftext: Vivian Weiwen Xue, et al. Cancers (Basel). 2020 Nov;12(11):3099.
pmc_ranked_result_index: '332'
pathway_score: 0.9396471
filename: cancers-12-03099-g001.jpg
figtitle: Transforming growth factorB (TGFB) signalling pathways in tumorigenesis
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7690808__cancers-12-03099-g001.html
  '@type': Dataset
  description: Transforming growth factor-β (TGF-β) signalling pathways in tumorigenesis.
    The dual roles of TGF-β signalling pathways have been demonstrated in tumorigenesis.
    TGF-β is a tumour suppressor in TME development of early-stage cancer and a tumour
    promoter in malignancy processes of advanced-stage cancer. Schematic diagramme
    (above) showing TGF-β signalling and its role in cancer tumorigenesis and progression
    as well as tumour suppression. TGF-β binds to TGFBR2 which then complexes with
    TGFBR1 to activate downstream signalling. TGF-β can activate both Smad-dependent
    canonical and Smad-independent non-canonical signalling cascades. The TGF-β activated
    TGFBR1 phosphorylates the Smad2/3 complex which then associates Smad4, before
    translocating to the nucleus to regulate the transcription of different targeted
    genes involved in tumour suppression during tumorigenesis (e.g., p15INK4b and
    p21Cip1), as well as tumour progression (e.g., Snail and Vimentin). The Smad-dependent
    TGF-β canonical signalling pathway can also be antagonised by Smad7 through inhibiting
    the binding of the Smad2/3 complex with Smad4. In the Smad-independent non-canonical
    signalling cascades, the activated TGFBR1/2 receptors induce downstream signalling
    through the Ras/Raf/MAPKs (JNK/p38/ERK), PI3K/AKT, MAP3K7(TAK1)/NF-κB, and Rho
    family of small GTPase-dependent signalling pathways. The TGF-β activated JNK/p38/ERK-MAPKs
    also crosstalk with Smad2/3/4 to modulate downstream signalling to influence cancer
    development. The Rho family of small GTPase-dependent signalling pathways (e.g.,
    Rho/ROCK) are involved in epithelial–mesenchymal transition (EMT). The activated
    PI3K/AKT pathway induces mTOR to promote cell proliferation and EMT. The TGF-β
    signals also activate NF-κB signalling to modulate inflammatory response.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFBR1
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - TGFBR2
  - SMAD7
  - RHOA
  - SMAD2
  - SMAD3
  - ARAF
  - BRAF
  - RAF1
  - AKT2
  - AKT3
  - AKT1
  - MAK
  - SMAD4
  - ROCK2
  - ROCK1
  - MKKS
  - MTOR
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - CDH1
  - VIM
  - TWIST1
  - Cancer
  - cancer
genes:
- word: TGFBRI
  symbol: TGFBR1
  source: hgnc_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: TGFBR2
  symbol: TGFBR2
  source: hgnc_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: Smad7
  symbol: SMAD7
  source: hgnc_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МАРЗКТ
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: MKKS
  symbol: MKKS
  source: hgnc_symbol
  hgnc_symbol: MKKS
  entrez: '8195'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: E-cadherin,MMPS
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: E-cadherin,
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: Vim
  symbol: VIM
  source: hgnc_symbol
  hgnc_symbol: VIM
  entrez: '7431'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Snail,C/EBPa,Twist
  symbol: TWIST
  source: hgnc_prev_symbol
  hgnc_symbol: TWIST1
  entrez: '7291'
- word: Twist
  symbol: TWIST
  source: hgnc_prev_symbol
  hgnc_symbol: TWIST1
  entrez: '7291'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
chemicals: []
diseases:
- word: Cancer
  source: MESH
  identifier: D009369
- word: cancer
  source: MESH
  identifier: D009369
---
